Get started
Author

Krishnath M. Jayatilleke

Observed names: K. Jayatilleke, Krishnath Jayatilleke, Krishnath M. Jayatilleke
Institution: La Trobe University
Observed institution: La Trobe University
OpenAlex ID: A5113934564
Heparanase and the hallmarks of cancer
2020 · Krishnath M. Jayatilleke, Mark D. Hulett · Journal of Translational Medicine · 155
PDF
Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival
2015 · Amelia J. Johnston, Kate T. Murphy, et al. · Cell · 152
PDF
Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2015 · Jai Rautela, Nikola Baschuk, et al. · Cancer Immunology Research · 78
PDF
Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer
2015 · Laura E. Edgington-Mitchell, Jai Rautela, et al. · Oncotarget · 52
PDF
Investigating the Role of Heparanase in Breast Cancer Development Utilising the MMTV-PyMT Murine Model of Mammary Carcinoma
2023 · Krishnath M. Jayatilleke, Hendrika M. Duivenvoorden, et al. · Cancers · 4
PDF
S-20
2014 · J. Rautela, N. Baschuk, et al. · Cytokine · 1
Data from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Supplementary Figure Legend from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Supplementary Figure 2 from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Supplementary Figure 4 from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Supplementary Figure 3 from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Supplementary Figure 1 from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Supplementary Figure 1 from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Supplementary Figure 4 from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Supplementary Figure 2 from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Supplementary Figure 3 from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Data from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
2023 · Jai Rautela, Nikola Baschuk, et al.
Heparanase in Breast Cancer Progression and the Characterisation of Novel Heparanase Inhibitors
2021 · Krishnath Jayatilleke · Figshare
Heparanase and the hallmarks of cancer
2020 · Krishnath Jayatilleke, Mark Hulett · La Trobe University
PO-220 Defining the role of heparanase in breast cancer progression using the PyMT-MMTV mouse model
2018 · K. Jayatilleke, H. Duivenvoorden, et al. · ESMO Open
Works count: 22
Citation count: 442
H-index: 4
I10-index: 4
Year
Topic
Type